Package 45802-873-05

Brand: nicotine polacrilex

Generic: nicotine polacrilex
NDC Package

Package Facts

Identity

Package NDC 45802-873-05
Digits Only 4580287305
Product NDC 45802-873
Product ID 45802-873_574b2fe4-a95b-400d-a107-4658e84f7d87
Description

3 CONTAINER in 1 CARTON (45802-873-05) / 24 LOZENGE in 1 CONTAINER (45802-873-03)

Marketing

Marketing Status
Marketed Since 2014-03-31
Brand nicotine polacrilex
Generic nicotine polacrilex
Sample Package No

Linked Drug Pages (1)

Nicotine Polacrilex ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "574b2fe4-a95b-400d-a107-4658e84f7d87", "openfda": {"nui": ["N0000175706", "M0014836"], "upc": ["0012345678905"], "unii": ["6M3C89ZY6R"], "rxcui": ["359818"], "spl_set_id": ["8d4dfba9-1571-4128-9cdc-47cdce04e3e4"], "pharm_class_cs": ["Nicotine [CS]"], "pharm_class_epc": ["Cholinergic Nicotinic Agonist [EPC]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 CONTAINER in 1 CARTON (45802-873-05)  / 24 LOZENGE in 1 CONTAINER (45802-873-03)", "package_ndc": "45802-873-05", "marketing_start_date": "20140331"}], "brand_name": "Nicotine Polacrilex", "product_id": "45802-873_574b2fe4-a95b-400d-a107-4658e84f7d87", "dosage_form": "LOZENGE", "pharm_class": ["Cholinergic Nicotinic Agonist [EPC]", "Nicotine [CS]"], "product_ndc": "45802-873", "generic_name": "Nicotine Polacrilex", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Nicotine Polacrilex", "active_ingredients": [{"name": "NICOTINE", "strength": "4 mg/1"}], "application_number": "ANDA077007", "marketing_category": "ANDA", "marketing_start_date": "20140331", "listing_expiration_date": "20261231"}